PETALING JAYA: Pharmaniaga Bhd
’s earnings forecast for the financial year 2020 and 2021 remains unchanged, pending further disclosure from the management on the earnings impact resulting from the fill-and-finish agreement, said MIDF Research.
The research house also reiterated its earlier view that the potential upside from the fill-and-finish as well as vaccine distribution will more or less be rather minimal on the company’s earnings.
“The procurement and bottling of Covid-19 vaccine from Sinovac by Pharmaniaga is expected to begin in the immediate future whilst the distribution is expected to take place at the end of March 2021, ” it said.
...